| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/09/2003 | CN1408413A Pellet capable of curing infantile anorexia and convulsion |
| 04/09/2003 | CN1408405A Medicne or health article containing behen vegetable |
| 04/09/2003 | CN1408401A Cherry extract and its extracting method |
| 04/09/2003 | CN1408400A Traditional Chinese medicinal wine for curing rheumatism and its preparing method |
| 04/09/2003 | CN1408399A Medicine for curing hyperthermia and its prepn |
| 04/09/2003 | CN1105114C Sulfonyl divalent aryl alpha-hydroxy-iso-hydroximic acid compounds |
| 04/09/2003 | CN1105112C Benzothiophenecarboxamide derivatives and PGD2 antagonist comprising them |
| 04/09/2003 | CN1105100C Compound with anti-inflammatory and immunosuppressive activities |
| 04/09/2003 | CN1104906C Tibetan-medicinal bath for treating rheumatism and its preparing process |
| 04/09/2003 | CN1104901C Medicinal preparation containing lipophilicity inert gas |
| 04/09/2003 | CN1104900C Use of 8,9-dehydroestrone as anti-oxidant |
| 04/09/2003 | CN1104895C Composition comprising tramadol material and acetaminophen and its use |
| 04/08/2003 | US6545182 Methods and compositions for modulating alpha adrenergic receptor activity |
| 04/08/2003 | US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease |
| 04/08/2003 | US6545050 Aryl sulphonamide amino acid esters and analogues |
| 04/08/2003 | US6545049 E.g., (2E, 4E, 6E)-7-(3,5-diisopropyl-2-n-heptyloxyphenyl)-3-methylocta-2,4,6-trienoic acid, esters or amides thereof |
| 04/08/2003 | US6545041 Tumor necrosis factor alpha (TNF-α) inhibiting pharmaceuticals |
| 04/08/2003 | US6545038 Heterocyclic metalloprotease inhibitors |
| 04/08/2003 | US6545030 1-heterocycle substituted diarylamines |
| 04/08/2003 | US6545025 Antiinflammatroy agents; antiallergens |
| 04/08/2003 | US6545023 For treating rheumatoid arthritis; for examle, 1-(4-(4-fluorophenyl)piperidin-1-yl),3-(2-methoxy-4 -chlorobenzylaminocarbonyl),3-isopropyl-cyclopentane |
| 04/08/2003 | US6545022 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammatory diseases, and gastrointestinal disorders |
| 04/08/2003 | US6545013 2,7-naphthyridine derivatives |
| 04/08/2003 | US6545004 Treating cellular proliferative diseases and disorders associated with KSP kinesin activity. |
| 04/08/2003 | US6545003 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/08/2003 | US6544993 Tetrahydrothiopyranphthalazinone derivatives as PDE4 inhibitors |
| 04/08/2003 | US6544991 Compositions and methods for treating bacterial infections |
| 04/08/2003 | US6544988 Tyrosine kinase inhibitors |
| 04/08/2003 | US6544981 Anticoagulants, cardiovascular disorders |
| 04/08/2003 | US6544977 Crystalline forms of 1s-[1-alpha(2s*,3r*), 9alpha]6, 10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9[[(1-isoquinolyl)carbonyl]amino]octahydro-6h-pyridazino [1,2-a] [1,2] diazepin-1-carboxamide |
| 04/08/2003 | US6544975 Mimetics that inhibit lipid peroxidation; for use in the treatment of diseases or disorders mediated by oxidative stress, such as asthma, inflammatory bowel disease, arthritis and vasculitis. |
| 04/08/2003 | US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation |
| 04/08/2003 | US6544561 Neutral to mildly alkaline; preventing and/or treating certain inflammatory diseases and/or degenerative diseases and/or certain viral diseases in a mammal |
| 04/08/2003 | US6544556 Prevents gastrointestinal side effects |
| 04/08/2003 | US6544550 Medicaments for gastrointestinal disorders |
| 04/08/2003 | US6544547 Nutritional composition containing methionine |
| 04/08/2003 | US6544541 Devices and compounds for treating arterial restenosis |
| 04/08/2003 | US6544530 Stable oil-in-glycerin emulsion |
| 04/08/2003 | CA2254152C New metalloprotease inhibitors, their preparation process and the pharmaceutical compositions which use them |
| 04/08/2003 | CA2184584C Vascular endothelial growth factor 2 |
| 04/08/2003 | CA2065849C Vitamin d analogues |
| 04/08/2003 | CA2062271C Derivatives of substituted imidazol-2-one and process for their preparation |
| 04/08/2003 | CA2053216C Saturated hydroxyalkylquinoline acids as leukotriene antagonists |
| 04/08/2003 | CA2050300C Tnf-inhibiting proteins and the preparation thereof |
| 04/08/2003 | CA2023810C Pharmaceutical composition |
| 04/07/2003 | WO2002032866A1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 04/04/2003 | WO2002030940A2 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 04/04/2003 | WO2002030896A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/04/2003 | CA2424979A1 2,2-diphenylbutanamide derivatives and medicines containing the same |
| 04/04/2003 | CA2424926A1 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals |
| 04/03/2003 | WO2003027316A2 Methods of using 33751, a human potassium channel family member |
| 04/03/2003 | WO2003027285A1 Dna sequences for human angiogenesis genes |
| 04/03/2003 | WO2003027282A1 Adamts-15, -16, -17, -18 and -19 |
| 04/03/2003 | WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/03/2003 | WO2003027263A2 Proteins associated with cell growth, differentiation, and death |
| 04/03/2003 | WO2003027228A2 Receptors and membrane-associated proteins |
| 04/03/2003 | WO2003027151A1 Recombinant anti-osteopontin antibody and use thereof |
| 04/03/2003 | WO2003027111A1 Chemical compounds |
| 04/03/2003 | WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 04/03/2003 | WO2003027090A2 Bicyclic heterocycles as rxr ligands |
| 04/03/2003 | WO2003027077A1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 04/03/2003 | WO2003027075A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 04/03/2003 | WO2003026697A2 Organoleptically acceptable intraorally disintegrating compositions |
| 04/03/2003 | WO2003026692A2 Treatment of chronic joint inflammation using an antibody against the cd3 antigen complex |
| 04/03/2003 | WO2003026677A1 Pharmaceutical composition comprising chito-oligomers |
| 04/03/2003 | WO2003026673A1 Modulation of vitamin storage |
| 04/03/2003 | WO2003026663A1 Process for making substituted pyrazoles |
| 04/03/2003 | WO2003026662A1 Solid-state forms of n-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl)pyrazole |
| 04/03/2003 | WO2003026660A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 04/03/2003 | WO2003026648A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 04/03/2003 | WO2003026644A1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
| 04/03/2003 | WO2003026623A1 Intraorally disintegrating valdecoxib compositions |
| 04/03/2003 | WO2003026579A2 Combination therapies for immune mediated diseases |
| 04/03/2003 | WO2003026568A2 Androstanes as androgen receptor modulators |
| 04/03/2003 | WO2003026479A2 Methods of suppressing microglial activation |
| 04/03/2003 | WO2003006104A3 Lymphatic endothelial cells materials and methods |
| 04/03/2003 | WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2002102313A3 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 04/03/2003 | WO2002100332A3 Isoxazoline compounds having mif antagonist activity |
| 04/03/2003 | WO2002094270A3 Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases |
| 04/03/2003 | WO2002092563A3 Protease inhibitors |
| 04/03/2003 | WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 04/03/2003 | WO2002073213A3 Assay |
| 04/03/2003 | WO2002070559A3 Nuclear hormone receptor ligand binding domains |
| 04/03/2003 | WO2002024909A9 Receptor nucleic acids and polypeptides |
| 04/03/2003 | WO2002022166A9 Tweak receptor agonists as anti-angiogenic agents |
| 04/03/2003 | WO2002010357A3 Gsk3 polypeptides |
| 04/03/2003 | WO2002007743A3 Piper methysticum plant extract |
| 04/03/2003 | WO2002000860A3 Novel proteases |
| 04/03/2003 | US20030065195 Ether compounds |
| 04/03/2003 | US20030065174 Antiinflammatory agents; analgesics |
| 04/03/2003 | US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis |
| 04/03/2003 | US20030065028 Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| 04/03/2003 | US20030065018 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 04/03/2003 | US20030065007 Analgesics; psychological disorders; antidepressants |
| 04/03/2003 | US20030064996 Anticarcinogenic agents, antiinflammatory agents, anticholesterol agents, antidiabetic agents |
| 04/03/2003 | US20030064987 Immunology moderators; interleukin antagonist; anticancer agents |
| 04/03/2003 | US20030064983 Headaches; antiarthritic agents; respiratory system disorders; psychological disorders |
| 04/03/2003 | US20030064958 Pharmaceutical compositions and methods relating to fucans |